Alimera Sciences Stock Gross Profit
| ALIMDelisted Stock | USD 5.54 0.01 0.18% |
Alimera Sciences fundamentals help investors to digest information that contributes to Alimera Sciences' financial success or failures. It also enables traders to predict the movement of Alimera Stock. The fundamental analysis module provides a way to measure Alimera Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alimera Sciences stock.
Alimera |
Alimera Sciences Company Gross Profit Analysis
Alimera Sciences' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Alimera Sciences Gross Profit | 52 M |
Most of Alimera Sciences' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alimera Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Alimera Sciences reported 52 M of gross profit. This is 97.68% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The gross profit for all United States stocks is 99.81% higher than that of the company.
Alimera Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alimera Sciences' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alimera Sciences could also be used in its relative valuation, which is a method of valuing Alimera Sciences by comparing valuation metrics of similar companies.Alimera Sciences is currently under evaluation in gross profit category among its peers.
Alimera Fundamentals
| Return On Equity | -0.35 | |||
| Return On Asset | 0.0098 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 360.44 M | |||
| Shares Outstanding | 54.38 M | |||
| Shares Owned By Insiders | 5.34 % | |||
| Shares Owned By Institutions | 86.54 % | |||
| Number Of Shares Shorted | 578.49 K | |||
| Price To Earning | 1.65 X | |||
| Price To Book | 7.77 X | |||
| Price To Sales | 3.02 X | |||
| Revenue | 80.75 M | |||
| Gross Profit | 52 M | |||
| EBITDA | 7.28 M | |||
| Net Income | (20.13 M) | |||
| Cash And Equivalents | 7.86 M | |||
| Cash Per Share | 1.12 X | |||
| Total Debt | 67.4 M | |||
| Current Ratio | 1.30 X | |||
| Book Value Per Share | 0.74 X | |||
| Cash Flow From Operations | (14.26 M) | |||
| Short Ratio | 1.93 X | |||
| Earnings Per Share | 1.05 X | |||
| Target Price | 5.67 | |||
| Number Of Employees | 154 | |||
| Beta | 1.25 | |||
| Market Capitalization | 301.29 M | |||
| Total Asset | 153.52 M | |||
| Retained Earnings | (418.49 M) | |||
| Working Capital | 30.51 M | |||
| Current Asset | 51.6 M | |||
| Current Liabilities | 7.85 M | |||
| Net Asset | 153.52 M |
About Alimera Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alimera Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alimera Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alimera Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Alimera Stock
If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |